Click for best price
Sleeping Pills Prescription Drugs Market Size, Share 2022
Market Analysis and Insights: Global Sleeping Pills Prescription Drugs Market
The global Sleeping Pills Prescription Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Sleeping Pills Prescription Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Sleeping Pills Prescription Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Sleeping Pills Prescription Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Sleeping Pills Prescription Drugs market.
Global Sleeping Pills Prescription Drugs Scope and Market Size
Sleeping Pills (Prescription Drugs) market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Sleeping Pills (Prescription Drugs) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Zolpidem
Eszopiclone (Lunesta)
Ramelteon (Rozerem)
Ativan (lorazepam)
Adapin (doxepin)
Segment by Application
Hospital Pharmacy
Retail Pharmacy
By Company
Sanofi
Abbott Laboratories
Takeda Pharmaceutical
Apotex
Aurobindo Pharma
Actellon Pharmaceuticals
Allegiant Health
Cayman Chemical
Ambitropin
Hayao
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The information for each competitor/Company Profile includes:
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
The content of the study subjects includes a total of 15 chapters:
Chapter 1, describes Sleeping Pills Prescription Drugs product scope, market overview, market opportunities, market driving force, and market risks.
Chapter 2, profiles the top manufacturers of Sleeping Pills Prescription Drugs, with price, sales, revenue, and global market share of Sleeping Pills Prescription Drugs from 2019 to 2022.
Chapter 3, the Sleeping Pills Prescription Drugs competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Sleeping Pills Prescription Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.
Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Sleeping Pills Prescription Drugs market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Sleeping Pills Prescription Drugs.
Chapter 13, 14, and 15, to describe Sleeping Pills Prescription Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Key Indicators Analysed:
- Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
- Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
- Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
- Opportunities and Drivers: Identifying the Growing Demands and New Technology
- Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Reasons to Purchase this Report:
- Estimates 2022-2027 2021-2025 Sleeping Pills Prescription Drugs Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
- 1-year analyst support, along with the data support in excel format.
Research Methodology:
The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
| Report Attributes |
Report Details |
| Report Title |
Global Sleeping Pills (Prescription Drugs) Market Insights, Forecast to 2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
111 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Study Coverage
1.1 Sleeping Pills (Prescription Drugs) Product Introduction
1.2 Market by Type
1.2.1 Global Sleeping Pills (Prescription Drugs) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Zolpidem
1.2.3 Eszopiclone (Lunesta)
1.2.4 Ramelteon (Rozerem)
1.2.5 Ativan (lorazepam)
1.2.6 Adapin (doxepin)
1.3 Market by Application
1.3.1 Global Sleeping Pills (Prescription Drugs) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Sleeping Pills (Prescription Drugs) Sales Estimates and Forecasts 2017-2028
2.2 Global Sleeping Pills (Prescription Drugs) Revenue Estimates and Forecasts 2017-2028
2.3 Global Sleeping Pills (Prescription Drugs) Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Sleeping Pills (Prescription Drugs) Sales by Region
2.4.1 Global Sleeping Pills (Prescription Drugs) Sales by Region (2017-2022)
2.4.2 Global Sales Sleeping Pills (Prescription Drugs) by Region (2023-2028)
2.5 Global Sleeping Pills (Prescription Drugs) Revenue by Region
2.5.1 Global Sleeping Pills (Prescription Drugs) Revenue by Region (2017-2022)
2.5.2 Global Sleeping Pills (Prescription Drugs) Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Sleeping Pills (Prescription Drugs) Sales by Manufacturers
3.1.1 Global Top Sleeping Pills (Prescription Drugs) Manufacturers by Sales (2017-2022)
3.1.2 Global Sleeping Pills (Prescription Drugs) Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Sleeping Pills (Prescription Drugs) in 2021
3.2 Global Sleeping Pills (Prescription Drugs) Revenue by Manufacturers
3.2.1 Global Sleeping Pills (Prescription Drugs) Revenue by Manufacturers (2017-2022)
3.2.2 Global Sleeping Pills (Prescription Drugs) Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Sleeping Pills (Prescription Drugs) Revenue in 2021
3.3 Global Sleeping Pills (Prescription Drugs) Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Sleeping Pills (Prescription Drugs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Sleeping Pills (Prescription Drugs) Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Sleeping Pills (Prescription Drugs) Sales by Type
4.1.1 Global Sleeping Pills (Prescription Drugs) Historical Sales by Type (2017-2022)
4.1.2 Global Sleeping Pills (Prescription Drugs) Forecasted Sales by Type (2023-2028)
4.1.3 Global Sleeping Pills (Prescription Drugs) Sales Market Share by Type (2017-2028)
4.2 Global Sleeping Pills (Prescription Drugs) Revenue by Type
4.2.1 Global Sleeping Pills (Prescription Drugs) Historical Revenue by Type (2017-2022)
4.2.2 Global Sleeping Pills (Prescription Drugs) Forecasted Revenue by Type (2023-2028)
4.2.3 Global Sleeping Pills (Prescription Drugs) Revenue Market Share by Type (2017-2028)
4.3 Global Sleeping Pills (Prescription Drugs) Price by Type
4.3.1 Global Sleeping Pills (Prescription Drugs) Price by Type (2017-2022)
4.3.2 Global Sleeping Pills (Prescription Drugs) Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Sleeping Pills (Prescription Drugs) Sales by Application
5.1.1 Global Sleeping Pills (Prescription Drugs) Historical Sales by Application (2017-2022)
5.1.2 Global Sleeping Pills (Prescription Drugs) Forecasted Sales by Application (2023-2028)
5.1.3 Global Sleeping Pills (Prescription Drugs) Sales Market Share by Application (2017-2028)
5.2 Global Sleeping Pills (Prescription Drugs) Revenue by Application
5.2.1 Global Sleeping Pills (Prescription Drugs) Historical Revenue by Application (2017-2022)
5.2.2 Global Sleeping Pills (Prescription Drugs) Forecasted Revenue by Application (2023-2028)
5.2.3 Global Sleeping Pills (Prescription Drugs) Revenue Market Share by Application (2017-2028)
5.3 Global Sleeping Pills (Prescription Drugs) Price by Application
5.3.1 Global Sleeping Pills (Prescription Drugs) Price by Application (2017-2022)
5.3.2 Global Sleeping Pills (Prescription Drugs) Price Forecast by Application (2023-2028)
6 North America
6.1 North America Sleeping Pills (Prescription Drugs) Market Size by Type
6.1.1 North America Sleeping Pills (Prescription Drugs) Sales by Type (2017-2028)
6.1.2 North America Sleeping Pills (Prescription Drugs) Revenue by Type (2017-2028)
6.2 North America Sleeping Pills (Prescription Drugs) Market Size by Application
6.2.1 North America Sleeping Pills (Prescription Drugs) Sales by Application (2017-2028)
6.2.2 North America Sleeping Pills (Prescription Drugs) Revenue by Application (2017-2028)
6.3 North America Sleeping Pills (Prescription Drugs) Market Size by Country
6.3.1 North America Sleeping Pills (Prescription Drugs) Sales by Country (2017-2028)
6.3.2 North America Sleeping Pills (Prescription Drugs) Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Sleeping Pills (Prescription Drugs) Market Size by Type
7.1.1 Europe Sleeping Pills (Prescription Drugs) Sales by Type (2017-2028)
7.1.2 Europe Sleeping Pills (Prescription Drugs) Revenue by Type (2017-2028)
7.2 Europe Sleeping Pills (Prescription Drugs) Market Size by Application
7.2.1 Europe Sleeping Pills (Prescription Drugs) Sales by Application (2017-2028)
7.2.2 Europe Sleeping Pills (Prescription Drugs) Revenue by Application (2017-2028)
7.3 Europe Sleeping Pills (Prescription Drugs) Market Size by Country
7.3.1 Europe Sleeping Pills (Prescription Drugs) Sales by Country (2017-2028)
7.3.2 Europe Sleeping Pills (Prescription Drugs) Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Sleeping Pills (Prescription Drugs) Market Size by Type
8.1.1 Asia Pacific Sleeping Pills (Prescription Drugs) Sales by Type (2017-2028)
8.1.2 Asia Pacific Sleeping Pills (Prescription Drugs) Revenue by Type (2017-2028)
8.2 Asia Pacific Sleeping Pills (Prescription Drugs) Market Size by Application
8.2.1 Asia Pacific Sleeping Pills (Prescription Drugs) Sales by Application (2017-2028)
8.2.2 Asia Pacific Sleeping Pills (Prescription Drugs) Revenue by Application (2017-2028)
8.3 Asia Pacific Sleeping Pills (Prescription Drugs) Market Size by Region
8.3.1 Asia Pacific Sleeping Pills (Prescription Drugs) Sales by Region (2017-2028)
8.3.2 Asia Pacific Sleeping Pills (Prescription Drugs) Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Sleeping Pills (Prescription Drugs) Market Size by Type
9.1.1 Latin America Sleeping Pills (Prescription Drugs) Sales by Type (2017-2028)
9.1.2 Latin America Sleeping Pills (Prescription Drugs) Revenue by Type (2017-2028)
9.2 Latin America Sleeping Pills (Prescription Drugs) Market Size by Application
9.2.1 Latin America Sleeping Pills (Prescription Drugs) Sales by Application (2017-2028)
9.2.2 Latin America Sleeping Pills (Prescription Drugs) Revenue by Application (2017-2028)
9.3 Latin America Sleeping Pills (Prescription Drugs) Market Size by Country
9.3.1 Latin America Sleeping Pills (Prescription Drugs) Sales by Country (2017-2028)
9.3.2 Latin America Sleeping Pills (Prescription Drugs) Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sleeping Pills (Prescription Drugs) Market Size by Type
10.1.1 Middle East and Africa Sleeping Pills (Prescription Drugs) Sales by Type (2017-2028)
10.1.2 Middle East and Africa Sleeping Pills (Prescription Drugs) Revenue by Type (2017-2028)
10.2 Middle East and Africa Sleeping Pills (Prescription Drugs) Market Size by Application
10.2.1 Middle East and Africa Sleeping Pills (Prescription Drugs) Sales by Application (2017-2028)
10.2.2 Middle East and Africa Sleeping Pills (Prescription Drugs) Revenue by Application (2017-2028)
10.3 Middle East and Africa Sleeping Pills (Prescription Drugs) Market Size by Country
10.3.1 Middle East and Africa Sleeping Pills (Prescription Drugs) Sales by Country (2017-2028)
10.3.2 Middle East and Africa Sleeping Pills (Prescription Drugs) Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Corporation Information
11.1.2 Sanofi Overview
11.1.3 Sanofi Sleeping Pills (Prescription Drugs) Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Sanofi Sleeping Pills (Prescription Drugs) Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Sanofi Recent Developments
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Corporation Information
11.2.2 Abbott Laboratories Overview
11.2.3 Abbott Laboratories Sleeping Pills (Prescription Drugs) Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Abbott Laboratories Sleeping Pills (Prescription Drugs) Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Abbott Laboratories Recent Developments
11.3 Takeda Pharmaceutical
11.3.1 Takeda Pharmaceutical Corporation Information
11.3.2 Takeda Pharmaceutical Overview
11.3.3 Takeda Pharmaceutical Sleeping Pills (Prescription Drugs) Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Takeda Pharmaceutical Sleeping Pills (Prescription Drugs) Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Takeda Pharmaceutical Recent Developments
11.4 Apotex
11.4.1 Apotex Corporation Information
11.4.2 Apotex Overview
11.4.3 Apotex Sleeping Pills (Prescription Drugs) Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Apotex Sleeping Pills (Prescription Drugs) Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Apotex Recent Developments
11.5 Aurobindo Pharma
11.5.1 Aurobindo Pharma Corporation Information
11.5.2 Aurobindo Pharma Overview
11.5.3 Aurobindo Pharma Sleeping Pills (Prescription Drugs) Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Aurobindo Pharma Sleeping Pills (Prescription Drugs) Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Aurobindo Pharma Recent Developments
11.6 Actellon Pharmaceuticals
11.6.1 Actellon Pharmaceuticals Corporation Information
11.6.2 Actellon Pharmaceuticals Overview
11.6.3 Actellon Pharmaceuticals Sleeping Pills (Prescription Drugs) Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Actellon Pharmaceuticals Sleeping Pills (Prescription Drugs) Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Actellon Pharmaceuticals Recent Developments
11.7 Allegiant Health
11.7.1 Allegiant Health Corporation Information
11.7.2 Allegiant Health Overview
11.7.3 Allegiant Health Sleeping Pills (Prescription Drugs) Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Allegiant Health Sleeping Pills (Prescription Drugs) Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Allegiant Health Recent Developments
11.8 Cayman Chemical
11.8.1 Cayman Chemical Corporation Information
11.8.2 Cayman Chemical Overview
11.8.3 Cayman Chemical Sleeping Pills (Prescription Drugs) Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Cayman Chemical Sleeping Pills (Prescription Drugs) Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Cayman Chemical Recent Developments
11.9 Ambitropin
11.9.1 Ambitropin Corporation Information
11.9.2 Ambitropin Overview
11.9.3 Ambitropin Sleeping Pills (Prescription Drugs) Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Ambitropin Sleeping Pills (Prescription Drugs) Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Ambitropin Recent Developments
11.10 Hayao
11.10.1 Hayao Corporation Information
11.10.2 Hayao Overview
11.10.3 Hayao Sleeping Pills (Prescription Drugs) Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Hayao Sleeping Pills (Prescription Drugs) Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Hayao Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Sleeping Pills (Prescription Drugs) Industry Chain Analysis
12.2 Sleeping Pills (Prescription Drugs) Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Sleeping Pills (Prescription Drugs) Production Mode & Process
12.4 Sleeping Pills (Prescription Drugs) Sales and Marketing
12.4.1 Sleeping Pills (Prescription Drugs) Sales Channels
12.4.2 Sleeping Pills (Prescription Drugs) Distributors
12.5 Sleeping Pills (Prescription Drugs) Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Sleeping Pills (Prescription Drugs) Industry Trends
13.2 Sleeping Pills (Prescription Drugs) Market Drivers
13.3 Sleeping Pills (Prescription Drugs) Market Challenges
13.4 Sleeping Pills (Prescription Drugs) Market Restraints
14 Key Findings in The Global Sleeping Pills (Prescription Drugs) Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Global Sleeping Pills (Prescription Drugs) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Zolpidem
Table 3. Major Manufacturers of Eszopiclone (Lunesta)
Table 4. Major Manufacturers of Ramelteon (Rozerem)
Table 5. Major Manufacturers of Ativan (lorazepam)
Table 6. Major Manufacturers of Adapin (doxepin)
Table 7. Global Sleeping Pills (Prescription Drugs) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Sleeping Pills (Prescription Drugs) Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 9. Global Sleeping Pills (Prescription Drugs) Sales by Region (2017-2022) & (K Units)
Table 10. Global Sleeping Pills (Prescription Drugs) Sales Market Share by Region (2017-2022)
Table 11. Global Sleeping Pills (Prescription Drugs) Sales by Region (2023-2028) & (K Units)
Table 12. Global Sleeping Pills (Prescription Drugs) Sales Market Share by Region (2023-2028)
Table 13. Global Sleeping Pills (Prescription Drugs) Revenue by Region (2017-2022) & (US$ Million)
Table 14. Global Sleeping Pills (Prescription Drugs) Revenue Market Share by Region (2017-2022)
Table 15. Global Sleeping Pills (Prescription Drugs) Revenue by Region (2023-2028) & (US$ Million)
Table 16. Global Sleeping Pills (Prescription Drugs) Revenue Market Share by Region (2023-2028)
Table 17. Global Sleeping Pills (Prescription Drugs) Sales by Manufacturers (2017-2022) & (K Units)
Table 18. Global Sleeping Pills (Prescription Drugs) Sales Share by Manufacturers (2017-2022)
Table 19. Global Sleeping Pills (Prescription Drugs) Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 20. Global Sleeping Pills (Prescription Drugs) Revenue Share by Manufacturers (2017-2022)
Table 21. Sleeping Pills (Prescription Drugs) Price by Manufacturers (2017-2022) &(USD/Unit)
Table 22. Global Sleeping Pills (Prescription Drugs) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Sleeping Pills (Prescription Drugs) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sleeping Pills (Prescription Drugs) as of 2021)
Table 24. Sleeping Pills (Prescription Drugs) Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Sleeping Pills (Prescription Drugs) Product Offered
Table 26. Date of Manufacturers Enter into Sleeping Pills (Prescription Drugs) Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Sleeping Pills (Prescription Drugs) Sales by Type (2017-2022) & (K Units)
Table 29. Global Sleeping Pills (Prescription Drugs) Sales by Type (2023-2028) & (K Units)
Table 30. Global Sleeping Pills (Prescription Drugs) Sales Share by Type (2017-2022)
Table 31. Global Sleeping Pills (Prescription Drugs) Sales Share by Type (2023-2028)
Table 32. Global Sleeping Pills (Prescription Drugs) Revenue by Type (2017-2022) & (US$ Million)
Table 33. Global Sleeping Pills (Prescription Drugs) Revenue by Type (2023-2028) & (US$ Million)
Table 34. Global Sleeping Pills (Prescription Drugs) Revenue Share by Type (2017-2022)
Table 35. Global Sleeping Pills (Prescription Drugs) Revenue Share by Type (2023-2028)
Table 36. Sleeping Pills (Prescription Drugs) Price by Type (2017-2022) & (USD/Unit)
Table 37. Global Sleeping Pills (Prescription Drugs) Price Forecast by Type (2023-2028) & (USD/Unit)
Table 38. Global Sleeping Pills (Prescription Drugs) Sales by Application (2017-2022) & (K Units)
Table 39. Global Sleeping Pills (Prescription Drugs) Sales by Application (2023-2028) & (K Units)
Table 40. Global Sleeping Pills (Prescription Drugs) Sales Share by Application (2017-2022)
Table 41. Global Sleeping Pills (Prescription Drugs) Sales Share by Application (2023-2028)
Table 42. Global Sleeping Pills (Prescription Drugs) Revenue by Application (2017-2022) & (US$ Million)
Table 43. Global Sleeping Pills (Prescription Drugs) Revenue by Application (2023-2028) & (US$ Million)
Table 44. Global Sleeping Pills (Prescription Drugs) Revenue Share by Application (2017-2022)
Table 45. Global Sleeping Pills (Prescription Drugs) Revenue Share by Application (2023-2028)
Table 46. Sleeping Pills (Prescription Drugs) Price by Application (2017-2022) & (USD/Unit)
Table 47. Global Sleeping Pills (Prescription Drugs) Price Forecast by Application (2023-2028) & (USD/Unit)
Table 48. North America Sleeping Pills (Prescription Drugs) Sales by Type (2017-2022) & (K Units)
Table 49. North America Sleeping Pills (Prescription Drugs) Sales by Type (2023-2028) & (K Units)
Table 50. North America Sleeping Pills (Prescription Drugs) Revenue by Type (2017-2022) & (US$ Million)
Table 51. North America Sleeping Pills (Prescription Drugs) Revenue by Type (2023-2028) & (US$ Million)
Table 52. North America Sleeping Pills (Prescription Drugs) Sales by Application (2017-2022) & (K Units)
Table 53. North America Sleeping Pills (Prescription Drugs) Sales by Application (2023-2028) & (K Units)
Table 54. North America Sleeping Pills (Prescription Drugs) Revenue by Application (2017-2022) & (US$ Million)
Table 55. North America Sleeping Pills (Prescription Drugs) Revenue by Application (2023-2028) & (US$ Million)
Table 56. North America Sleeping Pills (Prescription Drugs) Sales by Country (2017-2022) & (K Units)
Table 57. North America Sleeping Pills (Prescription Drugs) Sales by Country (2023-2028) & (K Units)
Table 58. North America Sleeping Pills (Prescription Drugs) Revenue by Country (2017-2022) & (US$ Million)
Table 59. North America Sleeping Pills (Prescription Drugs) Revenue by Country (2023-2028) & (US$ Million)
Table 60. Europe Sleeping Pills (Prescription Drugs) Sales by Type (2017-2022) & (K Units)
Table 61. Europe Sleeping Pills (Prescription Drugs) Sales by Type (2023-2028) & (K Units)
Table 62. Europe Sleeping Pills (Prescription Drugs) Revenue by Type (2017-2022) & (US$ Million)
Table 63. Europe Sleeping Pills (Prescription Drugs) Revenue by Type (2023-2028) & (US$ Million)
Table 64. Europe Sleeping Pills (Prescription Drugs) Sales by Application (2017-2022) & (K Units)
Table 65. Europe Sleeping Pills (Prescription Drugs) Sales by Application (2023-2028) & (K Units)
Table 66. Europe Sleeping Pills (Prescription Drugs) Revenue by Application (2017-2022) & (US$ Million)
Table 67. Europe Sleeping Pills (Prescription Drugs) Revenue by Application (2023-2028) & (US$ Million)
Table 68. Europe Sleeping Pills (Prescription Drugs) Sales by Country (2017-2022) & (K Units)
Table 69. Europe Sleeping Pills (Prescription Drugs) Sales by Country (2023-2028) & (K Units)
Table 70. Europe Sleeping Pills (Prescription Drugs) Revenue by Country (2017-2022) & (US$ Million)
Table 71. Europe Sleeping Pills (Prescription Drugs) Revenue by Country (2023-2028) & (US$ Million)
Table 72. Asia Pacific Sleeping Pills (Prescription Drugs) Sales by Type (2017-2022) & (K Units)
Table 73. Asia Pacific Sleeping Pills (Prescription Drugs) Sales by Type (2023-2028) & (K Units)
Table 74. Asia Pacific Sleeping Pills (Prescription Drugs) Revenue by Type (2017-2022) & (US$ Million)
Table 75. Asia Pacific Sleeping Pills (Prescription Drugs) Revenue by Type (2023-2028) & (US$ Million)
Table 76. Asia Pacific Sleeping Pills (Prescription Drugs) Sales by Application (2017-2022) & (K Units)
Table 77. Asia Pacific Sleeping Pills (Prescription Drugs) Sales by Application (2023-2028) & (K Units)
Table 78. Asia Pacific Sleeping Pills (Prescription Drugs) Revenue by Application (2017-2022) & (US$ Million)
Table 79. Asia Pacific Sleeping Pills (Prescription Drugs) Revenue by Application (2023-2028) & (US$ Million)
Table 80. Asia Pacific Sleeping Pills (Prescription Drugs) Sales by Region (2017-2022) & (K Units)
Table 81. Asia Pacific Sleeping Pills (Prescription Drugs) Sales by Region (2023-2028) & (K Units)
Table 82. Asia Pacific Sleeping Pills (Prescription Drugs) Revenue by Region (2017-2022) & (US$ Million)
Table 83. Asia Pacific Sleeping Pills (Prescription Drugs) Revenue by Region (2023-2028) & (US$ Million)
Table 84. Latin America Sleeping Pills (Prescription Drugs) Sales by Type (2017-2022) & (K Units)
Table 85. Latin America Sleeping Pills (Prescription Drugs) Sales by Type (2023-2028) & (K Units)
Table 86. Latin America Sleeping Pills (Prescription Drugs) Revenue by Type (2017-2022) & (US$ Million)
Table 87. Latin America Sleeping Pills (Prescription Drugs) Revenue by Type (2023-2028) & (US$ Million)
Table 88. Latin America Sleeping Pills (Prescription Drugs) Sales by Application (2017-2022) & (K Units)
Table 89. Latin America Sleeping Pills (Prescription Drugs) Sales by Application (2023-2028) & (K Units)
Table 90. Latin America Sleeping Pills (Prescription Drugs) Revenue by Application (2017-2022) & (US$ Million)
Table 91. Latin America Sleeping Pills (Prescription Drugs) Revenue by Application (2023-2028) & (US$ Million)
Table 92. Latin America Sleeping Pills (Prescription Drugs) Sales by Country (2017-2022) & (K Units)
Table 93. Latin America Sleeping Pills (Prescription Drugs) Sales by Country (2023-2028) & (K Units)
Table 94. Latin America Sleeping Pills (Prescription Drugs) Revenue by Country (2017-2022) & (US$ Million)
Table 95. Latin America Sleeping Pills (Prescription Drugs) Revenue by Country (2023-2028) & (US$ Million)
Table 96. Middle East and Africa Sleeping Pills (Prescription Drugs) Sales by Type (2017-2022) & (K Units)
Table 97. Middle East and Africa Sleeping Pills (Prescription Drugs) Sales by Type (2023-2028) & (K Units)
Table 98. Middle East and Africa Sleeping Pills (Prescription Drugs) Revenue by Type (2017-2022) & (US$ Million)
Table 99. Middle East and Africa Sleeping Pills (Prescription Drugs) Revenue by Type (2023-2028) & (US$ Million)
Table 100. Middle East and Africa Sleeping Pills (Prescription Drugs) Sales by Application (2017-2022) & (K Units)
Table 101. Middle East and Africa Sleeping Pills (Prescription Drugs) Sales by Application (2023-2028) & (K Units)
Table 102. Middle East and Africa Sleeping Pills (Prescription Drugs) Revenue by Application (2017-2022) & (US$ Million)
Table 103. Middle East and Africa Sleeping Pills (Prescription Drugs) Revenue by Application (2023-2028) & (US$ Million)
Table 104. Middle East and Africa Sleeping Pills (Prescription Drugs) Sales by Country (2017-2022) & (K Units)
Table 105. Middle East and Africa Sleeping Pills (Prescription Drugs) Sales by Country (2023-2028) & (K Units)
Table 106. Middle East and Africa Sleeping Pills (Prescription Drugs) Revenue by Country (2017-2022) & (US$ Million)
Table 107. Middle East and Africa Sleeping Pills (Prescription Drugs) Revenue by Country (2023-2028) & (US$ Million)
Table 108. Sanofi Corporation Information
Table 109. Sanofi Description and Major Businesses
Table 110. Sanofi Sleeping Pills (Prescription Drugs) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 111. Sanofi Sleeping Pills (Prescription Drugs) Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Sanofi Recent Developments
Table 113. Abbott Laboratories Corporation Information
Table 114. Abbott Laboratories Description and Major Businesses
Table 115. Abbott Laboratories Sleeping Pills (Prescription Drugs) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 116. Abbott Laboratories Sleeping Pills (Prescription Drugs) Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Abbott Laboratories Recent Developments
Table 118. Takeda Pharmaceutical Corporation Information
Table 119. Takeda Pharmaceutical Description and Major Businesses
Table 120. Takeda Pharmaceutical Sleeping Pills (Prescription Drugs) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 121. Takeda Pharmaceutical Sleeping Pills (Prescription Drugs) Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Takeda Pharmaceutical Recent Developments
Table 123. Apotex Corporation Information
Table 124. Apotex Description and Major Businesses
Table 125. Apotex Sleeping Pills (Prescription Drugs) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 126. Apotex Sleeping Pills (Prescription Drugs) Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Apotex Recent Developments
Table 128. Aurobindo Pharma Corporation Information
Table 129. Aurobindo Pharma Description and Major Businesses
Table 130. Aurobindo Pharma Sleeping Pills (Prescription Drugs) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 131. Aurobindo Pharma Sleeping Pills (Prescription Drugs) Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Aurobindo Pharma Recent Developments
Table 133. Actellon Pharmaceuticals Corporation Information
Table 134. Actellon Pharmaceuticals Description and Major Businesses
Table 135. Actellon Pharmaceuticals Sleeping Pills (Prescription Drugs) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 136. Actellon Pharmaceuticals Sleeping Pills (Prescription Drugs) Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Actellon Pharmaceuticals Recent Developments
Table 138. Allegiant Health Corporation Information
Table 139. Allegiant Health Description and Major Businesses
Table 140. Allegiant Health Sleeping Pills (Prescription Drugs) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 141. Allegiant Health Sleeping Pills (Prescription Drugs) Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Allegiant Health Recent Developments
Table 143. Cayman Chemical Corporation Information
Table 144. Cayman Chemical Description and Major Businesses
Table 145. Cayman Chemical Sleeping Pills (Prescription Drugs) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 146. Cayman Chemical Sleeping Pills (Prescription Drugs) Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. Cayman Chemical Recent Developments
Table 148. Ambitropin Corporation Information
Table 149. Ambitropin Description and Major Businesses
Table 150. Ambitropin Sleeping Pills (Prescription Drugs) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 151. Ambitropin Sleeping Pills (Prescription Drugs) Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. Ambitropin Recent Developments
Table 153. Hayao Corporation Information
Table 154. Hayao Description and Major Businesses
Table 155. Hayao Sleeping Pills (Prescription Drugs) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 156. Hayao Sleeping Pills (Prescription Drugs) Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. Hayao Recent Developments
Table 158. Key Raw Materials Lists
Table 159. Raw Materials Key Suppliers Lists
Table 160. Sleeping Pills (Prescription Drugs) Distributors List
Table 161. Sleeping Pills (Prescription Drugs) Customers List
Table 162. Sleeping Pills (Prescription Drugs) Market Trends
Table 163. Sleeping Pills (Prescription Drugs) Market Drivers
Table 164. Sleeping Pills (Prescription Drugs) Market Challenges
Table 165. Sleeping Pills (Prescription Drugs) Market Restraints
Table 166. Research Programs/Design for This Report
Table 167. Key Data Information from Secondary Sources
Table 168. Key Data Information from Primary Sources
List of Figures
Figure 1. Sleeping Pills (Prescription Drugs) Product Picture
Figure 3. Global Sleeping Pills (Prescription Drugs) Market Share by Type in 2021 & 2028
Figure 3. Zolpidem Product Picture
Figure 4. Eszopiclone (Lunesta) Product Picture
Figure 5. Ramelteon (Rozerem) Product Picture
Figure 6. Ativan (lorazepam) Product Picture
Figure 7. Adapin (doxepin) Product Picture
Figure 8. Global Sleeping Pills (Prescription Drugs) Market Share by Application in 2021 & 2028
Figure 9. Hospital Pharmacy
Figure 10. Retail Pharmacy
Figure 11. Sleeping Pills (Prescription Drugs) Report Years Considered
Figure 12. Global Sleeping Pills (Prescription Drugs) Sales 2017-2028 (K Units)
Figure 13. Global Sleeping Pills (Prescription Drugs) Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Sleeping Pills (Prescription Drugs) Revenue 2017-2028 (US$ Million)
Figure 15. Global Sleeping Pills (Prescription Drugs) Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 16. Global Sleeping Pills (Prescription Drugs) Sales Market Share by Region (2017-2022)
Figure 17. Global Sleeping Pills (Prescription Drugs) Sales Market Share by Region (2023-2028)
Figure 18. North America Sleeping Pills (Prescription Drugs) Sales YoY (2017-2028) & (K Units)
Figure 19. North America Sleeping Pills (Prescription Drugs) Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Europe Sleeping Pills (Prescription Drugs) Sales YoY (2017-2028) & (K Units)
Figure 21. Europe Sleeping Pills (Prescription Drugs) Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Asia-Pacific Sleeping Pills (Prescription Drugs) Sales YoY (2017-2028) & (K Units)
Figure 23. Asia-Pacific Sleeping Pills (Prescription Drugs) Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Latin America Sleeping Pills (Prescription Drugs) Sales YoY (2017-2028) & (K Units)
Figure 25. Latin America Sleeping Pills (Prescription Drugs) Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Middle East & Africa Sleeping Pills (Prescription Drugs) Sales YoY (2017-2028) & (K Units)
Figure 27. Middle East & Africa Sleeping Pills (Prescription Drugs) Revenue YoY (2017-2028) & (US$ Million)
Figure 28. The Sleeping Pills (Prescription Drugs) Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 29. The Top 5 and 10 Largest Manufacturers of Sleeping Pills (Prescription Drugs) in the World: Market Share by Sleeping Pills (Prescription Drugs) Revenue in 2021
Figure 30. Global Sleeping Pills (Prescription Drugs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 31. Global Sleeping Pills (Prescription Drugs) Sales Market Share by Type (2017-2028)
Figure 32. Global Sleeping Pills (Prescription Drugs) Revenue Market Share by Type (2017-2028)
Figure 33. Global Sleeping Pills (Prescription Drugs) Sales Market Share by Application (2017-2028)
Figure 34. Global Sleeping Pills (Prescription Drugs) Revenue Market Share by Application (2017-2028)
Figure 35. North America Sleeping Pills (Prescription Drugs) Sales Market Share by Type (2017-2028)
Figure 36. North America Sleeping Pills (Prescription Drugs) Revenue Market Share by Type (2017-2028)
Figure 37. North America Sleeping Pills (Prescription Drugs) Sales Market Share by Application (2017-2028)
Figure 38. North America Sleeping Pills (Prescription Drugs) Revenue Market Share by Application (2017-2028)
Figure 39. North America Sleeping Pills (Prescription Drugs) Sales Share by Country (2017-2028)
Figure 40. North America Sleeping Pills (Prescription Drugs) Revenue Share by Country (2017-2028)
Figure 41. U.S. Sleeping Pills (Prescription Drugs) Revenue (2017-2028) & (US$ Million)
Figure 42. Canada Sleeping Pills (Prescription Drugs) Revenue (2017-2028) & (US$ Million)
Figure 43. Europe Sleeping Pills (Prescription Drugs) Sales Market Share by Type (2017-2028)
Figure 44. Europe Sleeping Pills (Prescription Drugs) Revenue Market Share by Type (2017-2028)
Figure 45. Europe Sleeping Pills (Prescription Drugs) Sales Market Share by Application (2017-2028)
Figure 46. Europe Sleeping Pills (Prescription Drugs) Revenue Market Share by Application (2017-2028)
Figure 47. Europe Sleeping Pills (Prescription Drugs) Sales Share by Country (2017-2028)
Figure 48. Europe Sleeping Pills (Prescription Drugs) Revenue Share by Country (2017-2028)
Figure 49. Germany Sleeping Pills (Prescription Drugs) Revenue (2017-2028) & (US$ Million)
Figure 50. France Sleeping Pills (Prescription Drugs) Revenue (2017-2028) & (US$ Million)
Figure 51. U.K. Sleeping Pills (Prescription Drugs) Revenue (2017-2028) & (US$ Million)
Figure 52. Italy Sleeping Pills (Prescription Drugs) Revenue (2017-2028) & (US$ Million)
Figure 53. Russia Sleeping Pills (Prescription Drugs) Revenue (2017-2028) & (US$ Million)
Figure 54. Asia Pacific Sleeping Pills (Prescription Drugs) Sales Market Share by Type (2017-2028)
Figure 55. Asia Pacific Sleeping Pills (Prescription Drugs) Revenue Market Share by Type (2017-2028)
Figure 56. Asia Pacific Sleeping Pills (Prescription Drugs) Sales Market Share by Application (2017-2028)
Figure 57. Asia Pacific Sleeping Pills (Prescription Drugs) Revenue Market Share by Application (2017-2028)
Figure 58. Asia Pacific Sleeping Pills (Prescription Drugs) Sales Share by Region (2017-2028)
Figure 59. Asia Pacific Sleeping Pills (Prescription Drugs) Revenue Share by Region (2017-2028)
Figure 60. China Sleeping Pills (Prescription Drugs) Revenue (2017-2028) & (US$ Million)
Figure 61. Japan Sleeping Pills (Prescription Drugs) Revenue (2017-2028) & (US$ Million)
Figure 62. South Korea Sleeping Pills (Prescription Drugs) Revenue (2017-2028) & (US$ Million)
Figure 63. India Sleeping Pills (Prescription Drugs) Revenue (2017-2028) & (US$ Million)
Figure 64. Australia Sleeping Pills (Prescription Drugs) Revenue (2017-2028) & (US$ Million)
Figure 65. Taiwan Sleeping Pills (Prescription Drugs) Revenue (2017-2028) & (US$ Million)
Figure 66. Indonesia Sleeping Pills (Prescription Drugs) Revenue (2017-2028) & (US$ Million)
Figure 67. Thailand Sleeping Pills (Prescription Drugs) Revenue (2017-2028) & (US$ Million)
Figure 68. Malaysia Sleeping Pills (Prescription Drugs) Revenue (2017-2028) & (US$ Million)
Figure 69. Philippines Sleeping Pills (Prescription Drugs) Revenue (2017-2028) & (US$ Million)
Figure 70. Latin America Sleeping Pills (Prescription Drugs) Sales Market Share by Type (2017-2028)
Figure 71. Latin America Sleeping Pills (Prescription Drugs) Revenue Market Share by Type (2017-2028)
Figure 72. Latin America Sleeping Pills (Prescription Drugs) Sales Market Share by Application (2017-2028)
Figure 73. Latin America Sleeping Pills (Prescription Drugs) Revenue Market Share by Application (2017-2028)
Figure 74. Latin America Sleeping Pills (Prescription Drugs) Sales Share by Country (2017-2028)
Figure 75. Latin America Sleeping Pills (Prescription Drugs) Revenue Share by Country (2017-2028)
Figure 76. Mexico Sleeping Pills (Prescription Drugs) Revenue (2017-2028) & (US$ Million)
Figure 77. Brazil Sleeping Pills (Prescription Drugs) Revenue (2017-2028) & (US$ Million)
Figure 78. Argentina Sleeping Pills (Prescription Drugs) Revenue (2017-2028) & (US$ Million)
Figure 79. Middle East and Africa Sleeping Pills (Prescription Drugs) Sales Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Sleeping Pills (Prescription Drugs) Revenue Market Share by Type (2017-2028)
Figure 81. Middle East and Africa Sleeping Pills (Prescription Drugs) Sales Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Sleeping Pills (Prescription Drugs) Revenue Market Share by Application (2017-2028)
Figure 83. Middle East and Africa Sleeping Pills (Prescription Drugs) Sales Share by Country (2017-2028)
Figure 84. Middle East and Africa Sleeping Pills (Prescription Drugs) Revenue Share by Country (2017-2028)
Figure 85. Turkey Sleeping Pills (Prescription Drugs) Revenue (2017-2028) & (US$ Million)
Figure 86. Saudi Arabia Sleeping Pills (Prescription Drugs) Revenue (2017-2028) & (US$ Million)
Figure 87. U.A.E Sleeping Pills (Prescription Drugs) Revenue (2017-2028) & (US$ Million)
Figure 88. Sleeping Pills (Prescription Drugs) Value Chain
Figure 89. Sleeping Pills (Prescription Drugs) Production Process
Figure 90. Channels of Distribution
Figure 91. Distributors Profiles
Figure 92. Bottom-up and Top-down Approaches for This Report
Figure 93. Data Triangulation
Figure 94. Key Executives Interviewed
